Σάββατο 2 Φεβρουαρίου 2019

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Checkpoint protein inhibitor antibodies (CPI), including cytotoxic T-lymphocyte-associated antigen 4 inhibitors (ipilimumab, tremelimumab) and the programmed cell death protein 1 pathway/programmed cell death ...

from Emergency Medicine via xlomafota13 on Inoreader http://bit.ly/2SpMNDK

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου